Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Stieglitz

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Pediatric Blood & Cancer|October 24, 2020
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemiaCristina F Contreras, Christine S Higham, Astrid Behnert, et al.
Journal of Medical Genetics|April 9, 2016
Germline <i>RRAS2</i> mutations are not associated with Noonan syndromeJohn J Ceremsak, Ariel Yu, Emilio Esquivel, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Daple-FLT3 (CCDC88C-FLT3) gene fusion requires the coiled-coil domain for maximal activation and pericentrosomal localizationDarren Kao, Michael Acquazzino, Arnel Ibarra, et al.
Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.
Pediatric Blood & Cancer|March 5, 2025
Azacytidine Monotherapy in an Infant With Mosaic NRAS-Driven Juvenile Myelomonocytic LeukemiaJeremy M Grenier, Sarah K Tasian, Elliot Stieglitz, et al.
Leukemia|June 29, 2021
Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samplesAstrid Behnert, Julia Meyer, Jahan-Yar Parsa, et al.
Blood|March 1, 2014
Mutations in GATA2 are rare in juvenile myelomonocytic leukemiaElliot Stieglitz, Y Lucy Liu, Peter D Emanuel, et al.
Pediatric Blood & Cancer|July 27, 2019
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemiaAnna Hecht, Julia Meyer, Farid F Chehab, et al.
Cold Spring Harbor Molecular Case Studies|August 4, 2022
Detection of a GLIS3 fusion in an infant with AML refractory to chemotherapyStephen M Smith, Alex Lee, Schuyler Tong, et al.
Scientific Reports|December 22, 2019
Precision cancer monitoring using a novel, fully integrated, microfluidic array partitioning digital PCR platformMegan E Dueck, Robert Lin, Andrew Zayac, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Pediatric Blood & Cancer|October 24, 2020
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemiaCristina F Contreras, Christine S Higham, Astrid Behnert, et al.
Journal of Medical Genetics|April 9, 2016
Germline <i>RRAS2</i> mutations are not associated with Noonan syndromeJohn J Ceremsak, Ariel Yu, Emilio Esquivel, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Daple-FLT3 (CCDC88C-FLT3) gene fusion requires the coiled-coil domain for maximal activation and pericentrosomal localizationDarren Kao, Michael Acquazzino, Arnel Ibarra, et al.
Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.
Pediatric Blood & Cancer|March 5, 2025
Azacytidine Monotherapy in an Infant With Mosaic NRAS-Driven Juvenile Myelomonocytic LeukemiaJeremy M Grenier, Sarah K Tasian, Elliot Stieglitz, et al.
Leukemia|June 29, 2021
Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samplesAstrid Behnert, Julia Meyer, Jahan-Yar Parsa, et al.
Blood|March 1, 2014
Mutations in GATA2 are rare in juvenile myelomonocytic leukemiaElliot Stieglitz, Y Lucy Liu, Peter D Emanuel, et al.
Pediatric Blood & Cancer|July 27, 2019
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemiaAnna Hecht, Julia Meyer, Farid F Chehab, et al.
Cold Spring Harbor Molecular Case Studies|August 4, 2022
Detection of a GLIS3 fusion in an infant with AML refractory to chemotherapyStephen M Smith, Alex Lee, Schuyler Tong, et al.
Scientific Reports|December 22, 2019
Precision cancer monitoring using a novel, fully integrated, microfluidic array partitioning digital PCR platformMegan E Dueck, Robert Lin, Andrew Zayac, et al.
Pageof 9